Home » Stocks » ENVB

Enveric Biosciences, Inc. (ENVB)

Stock Price: $1.91 USD 0.01 (0.53%)
Updated May 14, 2021 4:00 PM EDT - Market closed
After-hours: $1.94 +0.03 (1.57%) May 14, 7:31 PM
Market Cap 41.80M
Revenue (ttm) 35.41M
Net Income (ttm) -6.86M
Shares Out 5.75M
EPS (ttm) -1.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $1.91
Previous Close $1.90
Change ($) 0.01
Change (%) 0.53%
Day's Open 1.90
Day's Range 1.85 - 2.00
Day's Volume 447,018
52-Week Range 1.85 - 21.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NAPLES, Fla., May 12, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve qualit...

4 days ago - PRNewsWire

NAPLES, FL / ACCESSWIRE / April 14, 2021 / Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality...

1 month ago - Accesswire

NAPLES, Fla., April 12, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve qual...

1 month ago - PRNewsWire

NAPLES, Fla., April 1, 2021 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid (CBD)_medicines to i...

1 month ago - PRNewsWire

NEW YORK, March 18, 2021 /PRNewswire/ --  Enveric Biosciences  (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve qualit...

1 month ago - PRNewsWire

LOS ANGELES, CA / ACCESSWIRE / March 17, 2021 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with David Johnson, Chairman, and CEO of Enveric...

1 month ago - Accesswire

ORLANDO, Fla., March 16, 2021 /PRNewswire/ -- Diverse Biotech, Inc. www.diversebiotech.com  announced today that it has finalized a strategic transaction with Enveric Biosciences to license exclusive wo...

2 months ago - PRNewsWire

NAPLES, Fla., March 15, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve qual...

2 months ago - PRNewsWire

Enveric (ENVB) stock has purchased the exclusive rights to research molecules that could lead to huge breakthroughs in CBD cancer treatment. The post ENVB Stock: Why Little-Known Enveric Biosciences is ...

2 months ago - InvestorPlace

Enveric Biosciences Inc (NASDAQ: ENVB) soars in the premarket in reaction to acquiring an exclusive, perpetual license for novel molecules from Diverse Biotech. It is a biopharmaceutical company focused...

2 months ago - Benzinga

NAPLES, Fla., March 10, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve qual...

2 months ago - PRNewsWire

NAPLES, Fla., Feb. 25, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quali...

2 months ago - PRNewsWire

NAPLES, Fla., Feb. 9, 2021 /PRNewswire/ -- Enveric Biosciences Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve q...

3 months ago - PRNewsWire

NEW YORK, Jan. 21, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...

3 months ago - PRNewsWire

NAPLES, Fla., Jan. 15, 2021 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve...

4 months ago - PRNewsWire

NAPLES, Fla., Dec. 31, 2020 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), formerly AMERI Holdings, Inc. (NASDAQ: AMRH), a patient-centric biotechnology company e...

Other stocks mentioned: AMRH
4 months ago - PRNewsWire

About ENVB

Enveric Biosciences, Inc., a biotechnology company, engages in developing various cannabinoid medicines to enhance quality of life for cancer patients. It has a pipeline of development programs for radiodermatitis, glioblastoma, and chemotherapy-induced neuropathy. The company is based in Naples, Florida.

Industry
Biotechnology
Founded
1994
CEO
Brent Kelton
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
ENVB
Full Company Profile

Financial Performance

Financial Statements